Issued Patents All Time
Showing 1–6 of 6 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12122819 | Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant | Laura D.J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew Onsum +2 more | 2024-10-22 |
| 12012442 | Activatable fusion protein and use thereof | Shey-Cherng Tzou, Yu-Yuan Hsiao, Fu-Yao Jiang, Chien-Yu Chou | 2024-06-18 |
| 11879002 | Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof | Laura D.J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew Onsum +2 more | 2024-01-23 |
| 11155593 | Method of inhibiting apoptosis or promoting cell survival by providing a bi-specific protein comprising insulin-like growth factor IGF-1 and Annexin A5 | Laura D.J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew Onsum +2 more | 2021-10-26 |
| 10633425 | Method of protecting tissue from damage by administering a bi-specific therapeutic protein comprising insulin-like growth factor 1 (IGF-1) and Annexin A5 | Laura D.J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew Onsum +2 more | 2020-04-28 |
| 10040840 | Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue | Laura D.J. Antipov, Shawdee Eshghi, Kristopher M. Kuchenbecker, Bjorn L. Millard, Matthew Onsum +2 more | 2018-08-07 |